Immediate angioplasty versus standard therapy with rescue 3 angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial

被引:272
作者
Di Mario, Carlo [1 ,2 ]
Dudek, Dariusz [3 ]
Piscione, Federico [4 ]
Mielecki, Waldemar [3 ]
Savonitto, Stefano [5 ]
Murena, Ernesto [6 ]
Dimopoulos, Konstantinos [1 ,2 ]
Manari, Antonio [7 ]
Gaspardone, Achille [8 ]
Ochala, Andrzej [9 ]
Zmudka, Krzysztof [10 ]
Bolognese, Leonardo [11 ]
Steg, Philippe Gabriel [12 ,13 ]
Flather, Marcus [1 ,2 ]
机构
[1] Royal Brompton Hosp, London SW3 6NP, England
[2] Univ London Imperial Coll Sci Technol & Med, London, England
[3] Jagiellonian Univ, Coll Med, Krakow, Poland
[4] Univ Naples Federico II, Naples, Italy
[5] Osped Niguarda Ca Granda, Milan, Italy
[6] Osped S Maria Grazie, Naples, Italy
[7] Arcispedale San Maria Nuova, Reggio Emilia, Italy
[8] Osped Sant Eugenio, Rome, Italy
[9] Gornoslaskie Ctr Kardiol, Katowice, Poland
[10] Spital Jana Pawla 2, Krakow, Poland
[11] Osped San Donato, Arezzo, Italy
[12] Univ Paris 07, Hop Bichat, INSERM, U 698, Paris, France
[13] Univ Paris 07, Hop Bichat, INSERM, APHP, Paris, France
关键词
D O I
10.1016/S0140-6736(08)60268-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infarction (STEMI) when primary percutaneous coronary intervention (PCI) cannot be done within 90 min. However, the best subsequent management of patients after thrombolytic therapy remains unclear. To assess the best management, we randomised patients with STEMI treated by thrombolysis and abciximab at a non-interventional hospital to immediate transfer for PCI, or to standard medical therapy with transfer for rescue angioplasty. Methods 600 patients aged 75 years or younger with one or more high-risk features (extensive ST-segment elevation, new-onset left bundle branch block, previous myocardial infarction, Killip class >2, or left ventricular ejection fraction <= 35%) in hospitals in France, Italy, and Poland were treated with half-dose reteplase, abciximab, heparin, and aspirin, and randomly assigned to immediate transfer to the nearest interventional Centre for PCI, or to management in the local hospital with transfer only in case of persistent ST-segment elevation or clinical deterioration. The primary outcome was a composite of death, reinfarction, or refractory ischaemia at 30 days, and analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number 00220571. Findings Of the 299 patients assigned to immediate PCI, 289 (97.0%) underwent angiography, and 255 (85.6%) received PCI. Rescue PCI was done in 91 patients (30.3%) in the standard care/rescue PCI group. The primary outcome occurred in 13 patients (4.4%) in the immediate PCI group compared with 32 (10.7%) in the standard care/rescue PCI group (hazard ratio 0 . 40; 95% CI 0 . 21-0.76, log rank p=0. 004). Major bleeding was seen in ten patients in the immediate group and seven in the standard care/rescue group (3.4% vs 2.3%, p=0.47). Strokes occurred in two patients in the immediate group and four in the standard care/rescue group (0.7% vs 1.3%, p=0 . 50). Interpretation Immediate transfer for PCI improves outcome in high-risk patients with STEMI treated at a non-interventional Centre with half-dose reteplase and abciximab.
引用
收藏
页码:559 / 568
页数:10
相关论文
共 33 条
[1]   Task force 1: The ACCF and AHA codes of conduct in human subjects research [J].
Adams, RJ ;
Antman, EM ;
Kavey, REW .
CIRCULATION, 2004, 110 (16) :2512-2516
[2]   A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction [J].
Andersen, HR ;
Nielsen, TT ;
Rasmussen, K ;
Thuesen, L ;
Kelbaek, H ;
Thayssen, P ;
Abildgaard, U ;
Pedersen, F ;
Madsen, JK ;
Grande, P ;
Villadsen, AB ;
Krusell, LR ;
Haghfelt, T ;
Lomholt, P ;
Husted, SE ;
Vigholt, E ;
Kjaergard, HK ;
Mortensen, LS .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) :733-742
[3]   Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14 [J].
Antman, EM ;
Gibson, CM ;
de Lemos, JA ;
Giugliano, RP ;
McCabe, CH ;
Coussement, P ;
Menown, I ;
Nienaber, CA ;
Rehders, TC ;
Frey, NJ ;
Van der Wieken, R ;
Andresen, D ;
Scherer, J ;
Anderson, K ;
Van de Werf, F ;
Braunwald, E .
EUROPEAN HEART JOURNAL, 2000, 21 (23) :1944-1953
[4]   Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction [J].
Antman, EM ;
Morrow, DA ;
McCabe, CH ;
Murphy, SA ;
Ruda, M ;
Sadowski, Z ;
Budaj, A ;
López-Sendón, JL ;
Guneri, S ;
Jiang, F ;
White, HD ;
Fox, KAA ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14) :1477-1488
[5]   Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology [J].
Bassand, JP ;
Danchin, N ;
Filippatos, G ;
Gitt, A ;
Hamm, C ;
Silber, S ;
Tubaro, M ;
Weidinger, F .
EUROPEAN HEART JOURNAL, 2005, 26 (24) :2733-2741
[6]   Strategies for reducing the door-to-balloon time in acute myocardial infarction [J].
Bradley, Elizabeth H. ;
Herrin, Jeph ;
Wang, Yongfei ;
Barton, Barbara A. ;
Webster, Tashonna R. ;
Mattera, Jennifer A. ;
Roumanis, Sarah A. ;
Curtis, Jeptha P. ;
Nallamothu, Brahmajee K. ;
Magid, David J. ;
McNamara, Robert L. ;
Parkosewich, Janet ;
Loeb, Jerod M. ;
Krumholz, Harlan M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2308-2320
[7]   Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial [J].
Chen, ZM ;
Jiang, LX ;
Chen, YP ;
Xie, JX ;
Pan, HC ;
Peto, R ;
Collins, R ;
Liu, LS ;
Chen, ZM ;
Liu, LS ;
Collins, R ;
Jiang, LX ;
Chen, YP ;
Xie, JX ;
Pan, HC ;
Peto, R ;
Cai, NS ;
Chen, YZ ;
Cui, JJ ;
Dai, GZ ;
Feng, JZ ;
Fu, SY ;
Gent, M ;
Gong, LS ;
Hu, DY ;
Huang, DJ ;
Huang, J ;
Huang, TG ;
Huang, ZW ;
Hui, RT ;
Jiang, BQ ;
Li, DY ;
Li, SM ;
Li, TD ;
Li, YQ ;
Li, ZQ ;
Liu, YH ;
Meng, QY ;
Qian, TJ ;
San, J ;
Tao, SQ ;
Wang, DW ;
Wang, LH ;
Wang, W ;
Wu, HA ;
Xi, WH ;
Xu, CB ;
Yang, DC ;
Yang, XF ;
Yin, JQ .
LANCET, 2005, 366 (9497) :1607-1621
[8]   Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS in AMI) [J].
Di Mario, C ;
Bolognese, L ;
Maillard, L ;
Dudek, D ;
Gambarati, G ;
Manari, A ;
Guiducci, V ;
Patrizi, G ;
Rusconi, LC ;
Piovaccari, G ;
Hibon, AR ;
Belpomme, V ;
Indolfi, C ;
Olivari, Z ;
Steffenino, G ;
Zmudka, K ;
Airoldi, F ;
Panzarasa, R ;
Flather, M ;
Steg, PG .
AMERICAN HEART JOURNAL, 2004, 148 (03) :378-385
[9]  
ELLIS S, FINESSE TRIAL
[10]   Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1):: a randomised controlled trial [J].
Fernandez-Avilés, F ;
Alonso, JJ ;
Castro-Beiras, A ;
Vázquez, N ;
Blanco, J ;
Alonso-Briales, J ;
López-Mesa, J ;
Fernández-Vazquez, F ;
Calvo, I ;
Martínez-Elbal, L ;
San Román, JA ;
Ramos, B .
LANCET, 2004, 364 (9439) :1045-1053